Welcome to the Society for Clinical Trials

A Message from 2017-2018 SCT President, Theodore G. Karrison, PhD




2017-2018 SCT President, Theodore G. Karrison, PhD

Hello! I am privileged to serve as your President and to welcome both new and old members to the Society. The Society for Clinical Trials (SCT) is a scientific, educational, and charitable organization whose mission is to work internationally to advance human health through advocating the use of clinical trials, leading the development and dissemination of optimal methods and practices in clinical trials, and educating and developing clinical trial professionals. We accomplish this mission through our annual scientific meeting, which includes invited and contributed sessions, poster presentations, and educational short courses and workshops; our highly regarded journal Clinical Trials; our ongoing webinar series; and our many outreach activities. The Society is currently in its 39th year and our members come from academia, industry, government and non-profit research and advocacy groups. We are a multidisciplinary society consisting of clinical investigators, biostatisticians, project managers, IT specialists, clinical research associates and other specialists engaged in the design, conduct, and analysis of clinical trials. We are a truly international organization, as evidenced by our 2017 annual meeting, which was co-sponsored by the MRC Hubs Network and held in Liverpool, England. We also sponsor the SCT-QSPI (Quantitative Sciences in the Pharmaceutical Industry) workshop, which is held biannually in the Washington, DC area. This workshop brings together statisticians and other specialists from industry, the U.S. FDA, and academia.

SCT RSS Subscription  CLINICAL TRIALS RSS:


Neurobiological mechanisms of exercise and psychotherapy in depression: The SPeED study—Rationale, design, and methodological issues

Characteristics and trends of clinical trials funded by the National Institutes of Health between 2005 and 2015

PrEP Chicago: A randomized controlled peer change agent intervention to promote the adoption of pre-exposure prophylaxis for HIV prevention among young Black men who have sex with men

Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols

University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion)

Comparisons of cancer staging systems should be based on overall performance in the population

An evaluation of the effectiveness of a risk-based monitoring approach implemented with clinical trials involving implantable cardiac medical devices

Evaluating biomarkers for prognostic enrichment of clinical trials

The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs

Sample size adjustment designs with time-to-event outcomes: A caution

Use of an android phone application for automated text messages in international settings: A case study in an HIV clinical trial in St. Petersburg, Russia

Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research

Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study

Isotonic designs for phase I trials in partially ordered groups

University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (afternoon panel discussion)

Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?

Power estimation in biomarker studies where events are already observed

Commentary on Freidlin and Korn

Rejoinder

Phase 1 healthy volunteer willingness to participate and enrollment preferences

Commentary on Heath et al.

Repeated measures dose-finding design with time-trend detection in the presence of correlated toxicity data

Commentary on Grady et al.: Using poor, uninsured minorities to test the safety of experimental drugs

Response to Kerr et al

Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemia

Response

Primary care physicians’ attitudes and beliefs about cancer clinical trials

Evidence of bias in randomized clinical trials of hepatitis C interferon therapies

Commentary on Tinè et al.

Group sequential designs for stepped-wedge cluster randomised trials

A web application for evaluating Phase I methods using a non-parametric optimal benchmark

The impact of data errors on the outcome of randomized clinical trials

Re-randomization tests for unplanned changes in clinical trials

Adaptive designs: The Swiss Army knife among clinical trial designs?

Adaptive designs from a Data Safety Monitoring Board perspective: Some controversies and some case studies

A simulation study of outcome adaptive randomization in multi-arm clinical trials

SCT RSS Subscription  Subscribe RSS


 

SCT Newsletter

SCT Newsletter Current Issue (vol 12):
President's Corner, Workshops, Seminars, Committee Updates, Webinars, Annual Meeting Promotion, Upcoming Events and more...
  Download June 2017 Issue »
 

David Sackett Trial of the Year

SCT Trial of the Year Award
10th Annual Award (2016)
“Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis (ORATORIO)”
Read Full Press Release »
 

SCT Brochure

SCT Newsletter Society for Clinical Trials
An international professional organization dedicated to the theory and practice of clinical trials.
 Download Brochure »